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Abstract 
Introduction:  Emergence delirium (ED) is a mental disturbance sometimes occurring 
during recovery from general anesthesia.  ED presents as hallucinations and confusion, 
evidenced by moaning, restlessness, involuntary physical activity, and is considered a 
common post-anesthetic problem in children.  This study investigated the role of 
preoperative dexmedetomidine on parental separation anxiety and anesthesia mask 
acceptance and its effectiveness in reducing the incidence and severity of ED.  
Methods:  A double-blind pilot study was conducted with 41 children, 1-6 years of age, 
undergoing dental restoration and/or extractions under general anesthesia.  Subjects were 
given 4µg/kg dexmedetomidine (Group A) or 0.5 mg/kg midazolam (Group B) orally, 
prior to anesthesia induction.  General anesthesia was initiated using 6% sevoflurane in 
50% O  with 50% N O and was maintained 2 2 with 0.8-1.5% isoflurane.  Subjects were 
evaluated using the Parental Separation Tool and the Anesthesia Mask Acceptance Tool.  
Following extubation the subjects were transported to the post-anesthesia recovery room 
and evaluated using the Pediatric Anesthesia Emergence Delirium Scale. 
Results:  There was no significant difference between Groups A and B in parental 
separation anxiety (P=0.138; Pearson Chi-Square) or anesthesia mask acceptance 
(P=0.438; Pearson Chi-Square).  In addition, Group A showed no significant difference 
in occurrence of ED compared to Group B (P=0.313, independent t-test).  Interestingly, 
males in Group B were 15.75 times more likely to experience parental separation anxiety 
than males in Group A.  This difference was found to be statistically significant with 
P=0.011 by Pearson Chi-Square and P=0.024 by Fischer’s Exact Test.   
 vii
Conclusions:  The clinically significant finding of this investigation is that 
dexmedetomidine (4µg/kg) is equally as effective as midazolam (0.5mg/kg) in preventing 
parental separation difficulty and easing acceptance of the anesthetic mask in pediatric 
patients 1-6 years of age.  However, dexmedetomidine is not significantly effective in 
preventing the occurrence of ED in this pediatric patient population.   
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Chapter 1 
 
Introduction 
 
 Emergence delirium (ED) has been described as “…a mental disturbance during 
the recovery from general anesthesia consisting of hallucinations, delusions and 
confusion manifested by moaning, restlessness, involuntary physical activity, and 
thrashing about in bed”(Sikich & Lerman, 2004).  This phenomenon has been considered 
a common post-anesthetic problem in children and adults since its description in the 
literature in 1960.  According to Cole, Muray, McAllister & Hirshberg (2002), ED occurs 
most frequently in the initial ten minutes of recovery, but many children who arrive in a 
post-anesthesia recovery area asleep experience agitation later during recovery.  There 
are multiple definitions of ED in the literature, with associated prevalence in children 
ranging from 25-80%, and typically occurring within the first 30 minutes following 
emergence from anesthesia (Sikich & Lerman, 2004).  The most plausible reason for the 
range in reported prevalence of ED in children is likely attributable to the diversity in 
definition.  Likewise, the reported severity of emergence delirium in the pediatric 
anesthesia population has varied widely between observers, with the one constant being 
an almost universally unpredictable presentation. 
Dexmedetomidine 
Dexmedetomidine is an alpha (α) adrenergic agonist that has a greater specificity 
for the α-2 receptor versus the α-1 receptor (300:1 for clonidine compared to 1620:1 for 
dexmedetomidine). (Kamibayashi, Maze, 2000; Smith, Elliott, 2001) “These centrally 
acting α-2 adrenergic agonists activate receptors in the medullary vasomotor center, 
reducing norepinephrine turnover and decreasing central sympathetic outflow.  These 
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agents also increase parasympathetic outflow and inhibit sympathetic outflow from the 
locus ceruleus in the brainstem.  The decreased noradrenergic output from the locus 
ceruleus results in increased firing of inhibitory neurons including the γ-amino butyric 
acid (GABA) system resulting in sedation, anxiolysis, and analgesia” (Zub, Berkenbosch, 
& Tobias, 2005).   
As stated by Ebert, Hall, and Barney, Uhrich, & Colinco (2000), 
dexmedetomidine is able to induce a state of “unconsciousness in which subjects could 
not be aroused by vigorous shaking”, while at the same time, subjects where able to 
maintain adequate respiratory function.  According to the manufacturer, the most 
common side effects of dexmedetomidine include nausea and vomiting, bradycardia, 
hypotension and fever. 
Midazolam 
Midazolam is a benzodiazepine that has sedative, amnesic, anxiolytic, and 
hypnotic qualities.  Benzodiazepine’s pharmacologic effects appear to result from 
reversible interactions with the (gamma)-amino butyric acid (GABA) benzodiazepine 
receptor in the CNS, the major inhibitory neurotransmitter in the central nervous system 
(Stoelting, & Hillier, 2006).  According to the manufacturer, the most common side 
effects include amnesia, headache, drowsiness, confusion, blood pressure changes, 
nausea and vomiting, and coughing.  However, professional experience with 
benzodiazepines has consistently demonstrated the potential for profound respiratory 
depression with the use of benzodiazepines.  This effect may be especially unpredictable 
when midazolam is administered in higher doses or administered in combination with 
other drugs that also exhibit respiratory depressant effect. 
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Consequently, investigation into this topical area is both needed and justified in order 
to seek the safest and most effective interventions for dealing with the phenomenon of 
emergence delirium.  To that end, the focus of this study will seek to investigate the role 
and effectiveness of preoperative oral dexmedetomidine administration upon the 
incidence, prevalence, and severity of emergence delirium in children aged one to six 
years undergoing dental restoration with or without dental extraction.   
Research Questions 
The questions this research seeks to answer are as follows:   
1. Does orally administered dexmedetomidine promote better parental separation 
and acceptance of an anesthesia face mask as compared to orally administered 
midazolam in children aged one to six years having dental restoration, with or 
without dental extractions? 
2. Does orally administered dexmedetomidine affect the incidence and severity 
of emergence delirium in children aged one to six years having dental 
restoration, with or without dental extractions, as compared to orally 
administered midazolam for the same population undergoing the same 
procedures? 
Null Hypothesis 
In search of the answers to the research questions posed, this author will seek to address 
the null hypothesis:   
There will be no difference in the incidence or severity of emergence delirium as 
measured by the Pediatric Anesthesia Emergence Delirium Scale (PAEDS) in 
subjects aged one to six years who receive oral dexmedetomidine compared to 
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subjects aged one to six years who receive oral midazolam as an anesthetic pre-
medication prior to dental restoration, with or without dental extractions. 
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Chapter II 
Review of the Literature 
 
 According to the forth edition of the Diagnostic and Statistical Manual of Mental 
Disorders, delirium is defined as “a disturbance of consciousness with reduced ability to 
focus, sustain, or shift attention; a change in cognition (memory deficit, disorientation, 
language disturbance); or the development of a perceptual disturbance that occurs over a 
short period of time and tends to fluctuate over the course of a day” (American 
Psychiatric Association, 2000). Emergence delirium has been considered a common post-
anesthetic problem in children and adults.  The prevalence of Emergence Delirium (ED) 
in children ranges from 25-80%, depending on the definition of ED.  Sikich & Lerman 
(2004) determined that ED usually occurs within the first 30 minutes after anesthesia 
emergence. In a study published in 2001, Veyckemans found documented situations 
where ED associated agitation was recorded as long as two days post-operatively.  
Emergence Delirium Defined 
 Several terms and definitions for ED have been used interchangeably within the 
greater body of literature, thereby confounding consistent identification and labeling by 
health professionals and researchers.  Emergence delirium, emergence agitation, and 
post-anesthetic excitement all are characterized by severe restlessness, nonpurposeful 
movement, disorientation, incoherence, unresponsiveness, thrashing, and kicking 
(Manworren, Paulos, & Pop).  Some of the distinct but common features of this 
phenomenon, regardless of nomenclature, include; acute onset of signs and symptoms, 
variable duration of signs and symptoms, acute onset of new disabilities, acute 
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incoherency, and spontaneous resolution with treatment (O’Brien, D., 2002).  According 
to Voepel-Lewis, Malviya, and Tait (2003) ED includes nonpurposeful restlessness and 
agitation, thrashing, crying or moaning, disorientation, and incoherence.  This definition 
of emergence delirium will be utilized by this author in this manuscript as an operational 
definition. 
Research on Clonidine 
 Malviya et al. performed a double blind study comparing the effectiveness of 
clonidine to a placebo for the prevention of ED.  In their study, the researchers observed 
129 subjects, 59 in clonidine group that received 2mcg/kg IV following induction, and 61 
in placebo group. Although the clonidine group experienced increased sleepiness, they 
also experienced less severe agitation.  In this investigation, six subjects (10%) in the 
clonidine group, as compared to 16 subjects (26%) in the placebo group, were identified 
as moderately to severely agitated upon emergence as evidenced by a score of three or 
four on a four-point agitation evaluation tool.  The possible scores on their tool ranged 
from zero = quiet, calm; one = mildly agitated but consolable; three = moderately 
agitated, nonpurposeful and inconsolable; four = severely agitated.  Although both groups 
required analgesia post operatively, clonidine six (10%) and placebo four (7%), the 
investigators determined the utilization of Clonidine preoperatively significantly reduced 
the incidence of emergence agitation without altering hemodynamic status.  Interestingly, 
the investigators reported that the parents of the subjects preferred for their children to be 
asleep and calm rather than awake and alert upon discharge. 
 Another scientifically sound research study examined the prevention of 
emergence agitation in association with the use of either tropisetron or clonidine after 
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sevoflurane anesthesia in subjects undergoing adenoidectomy. In contrast to Malviya et 
al., which also examined the role of Clonidine in attenuating the effects of ED in 
children, the Clonidine dosage in this investigation was reduced to 1.5mcg/kg IV as 
compared to 2mcg/kg IV after induction.  (Lankinen, Avela, & Tarkkila, 2006) 
The researchers observed 75 subjects aged one to seven assigned to one of three groups: 
26 in the placebo group, 25 in the tropisetron group (0.1mg/kg IV after induction), and 24 
in the clonidine group (1.5mcg/kg IV after induction).  It was observed in this 
investigation that emergence agitation was less severe in the tropisetron group, eight 
(32%), compared to the placebo group, sixteen (62%) and the clonidine group was 
observed to have not prevented emergence agitation with thirteen (54%).  These authors 
utilized the modified Aldrete and pain/ discomfort scales to measure agitation in the 
subjects under investigation.   
Development of Dexmedetomidine 
 
 Although not specifically developed for ED, dexmedetomidine was developed to 
satisfy the need for a drug having the specificity to act upon α-2 receptors without 
inducing the negative effects associated with the activation of the α-1 receptors.  
However, the agent’s CNS effects, however, would suggest it could be a useful anesthetic 
adjuvant to attenuate or prevent ED.   Dexmedetomidine is an alpha (α) adrenergic 
agonist that has a greater specificity for the α-2 receptor, primarily found on the 
presynaptic membrane, versus the α-1 receptor, primarily found on the postsynaptic 
membrane. Compared to clonidine, with a 300:1 affinity to the α-2 receptor, 
dexmedetomidine has a 1620:1 affinity to the f α-2 receptor. (Kamibayashi, Maze, 2000; 
Smith, Elliott, 2001).  At this time, dexmedetomidine is routinely being used for short-
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term sedation of patients requiring mechanical ventilation in the intensive care unit (ICU) 
setting.  Concurrently, some practitioners are beginning to utilize the agent as a 
preanesthetic medication in minor and major surgical procedures.  This agent is useful in 
anesthetist’s pharmacological armamentarium because it is capable of attenuating the 
sympathetic response that occurs with intubations and so may decrease the total dosage 
of opioids necessary for the induction of general anesthesia.   
Dexmedetomidine Research 
 While evaluating the use of dexmedetomidine in the pediatric population 
undergoing cardiac surgery, Mukhtar, Obayah, and Hassona (2006) found that 
dexmedetomidine use resulted in decreased HR, MAP, and a reduction in cortisol, 
catecholamines, and blood glucose levels when measured in these patients as markers of 
surgical stress response.  The conclusion these researchers postulated was that 
“dexmedetomidine can be a useful adjunct in pediatric cardiac anesthesia because it 
attenuates the hemodynamic and neuroendocrinal response of surgical trauma and 
cardiopulmonary bypass”. 
 Mason et al. studied the use of dexmedetomidine for sedation in pediatric patients 
undergoing computed tomography (CT) imaging studies.  They reported that 
dexmedetomidine was a reliable and effective drug to use for CT imaging, providing 
adequate sedation without a negative effect on baseline respiration.  A similar study 
compared propofol with dexmedetomidine in the pediatric population undergoing 
magnetic resonance imaging (MRI).  These authors concluded that, while propofol 
provided quicker onset and emergence in this subject population, dexmedetomidine 
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preserved mean arterial pressure, respiratory rate without any episodes of arterial 
desaturations (Koroglu et al., 2006). 
Emergence Delirium Research with Children 
While studying the incidence of ED in children following general anesthesia, 
Cole, Murray, McAllister, and Hirshberg (2002) observed 260 subjects between the ages 
of ten months and six years with a mean age of 2.7 years old.  It was reported in their 
study that 37% (79/260) of the subjects experienced ED.   In relation to their 
investigation; 
One of the factors believed to contribute to a higher frequency of 
emergence agitation is a rapid emergence in a foreign environment.  We found 
that children who were asleep for the initial three measurement periods in the 
recovery room had a similar incidence of emergence agitation (22%) compared 
with the remainder of the group” (p. 447). 
As a result of their investigation, the influence of rapid emergence and awakening from 
anesthesia in a foreign environment were taken into consideration during the planning of 
this author’s study. 
Of the five hundred twenty-one pediatric subjects aged three through seven who 
were enrolled in a study by Voepel-Lewis, Malviya, and Tait (2003), 96 (18%) 
experienced some measure of ED.  The observed symptoms ranged in duration from three 
to forty-five minutes with an average length of occurrence of fourteen minutes.  These 
subjects required pharmacological intervention to control their symptoms, which included 
thrashing, kicking, restlessness, and incoherency.  As a consequence of the interventions 
necessitated by the exhibited behaviors of the subjects, the subjects as a group were 
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observed to require longer than estimated lengths of stay in the postanesthisia care unit.   
Post Anesthesia Care Unit stay for these subjects averaged 117 minutes, resulting in an 
increased average length of stay by more than 15 minutes when compared to individuals 
not needing the interventions required by those who exhibited these symptoms.  More 
than half (fifty-six) of the subjects in the ED group required physical restraint, which was 
defined as being held down by a nurse.  A significant percentage of this group (42%) 
required two or more nurses to physically restrain them until the agitation had subsided 
and the threats to their safety had passed (Voepel-Lewis, Malviya, & Tait, 2003).  
According to Voepel et al, in the discussion of their findings, the delirium observed was 
associated with five adverse advents including increased bleeding from the surgical site, 
dislodgement of a surgical drain, complaint of increased pain at the operative site and 
minor injury to the attending nurse.   
   Shurkey, Mathison, Kalarickal, and Ramadhyani (2006) conducted a study 
involving two groups of pediatric subjects.  One group received intravenous 
Dexmedetomidine initiated at the time of induction and continued intraoperatively, 
accompanied by the administration of a sevoflurane-based volatile general anesthesia.  
The other group received the same volatile general anesthetic, but received an 
intravenous placebo in place of the dexmedetomidine.  According to the authors, upon 
emergence “the incidence of agitation was significantly different between the two groups, 
26% in the dexmedetomidine group versus 60.8% in the placebo group with a p value of 
0.036.  Additionally, the frequency of observed episodes of agitation was lower in the 
dexmedetomidine group (p<0.017).  However, despite the reduction in observed signs 
and symptoms of ED, the time from extubation until discharge from PACU was the same 
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for both groups (Shurkey, Mathison, Kalarickal, & Ramadhyani, 2006).  Shurkey et al. 
state that, when compared to benzodiazepines or opioids, dexmedetomidine has a shorter 
half-life and exhibits less respiratory depression.  Based on their conclusions, potential 
benefits in ED symptom control could be expected with the utilization of 
dexmedetomidine as compared to the utilization of benzodiazepines while at the same 
time resulting in a lower potential for the negative side effect of respiratory depression. 
  Ibacache, Muñoz, Brandes, and Morales, researchers at the Pontificia 
Universidad Católica de Chile, in Santiago, Chile, studied single dose dexmedetomidine 
intravenously following the administration of a sevoflurane-based anesthesia in children.  
They enrolled 90 subjects aged one to ten in their study.  Their subjects underwent 
inguinal hernia repair, orchiopexy, or circumcision.  They received sevoflurane in 
combination with a caudal block.  None of the subjects received any premedication.  
“Group 1 (n=30) received saline 10ml, Group 2 (n=30) received dexmedetomidine 
0.15μg/kg, and Group 3 (n=30) received dexmedetomidine 0.30μg/kg” (Ibacache, 
Muñoz, Brandes, & Morales, 2003, p. 60).  Ibacache, Muñoz, Brandes, and Morales 
(2003) state that their confidence interval was 95% with the incidence of agitation was 
37% in Group 1, 17% in Group 2, and only 10% in group 3 with P < 0.05.  The authors 
stated that dexmedetomidine significantly decreased the occurrence of emergence 
agitation when administered to subjects in their study at the 0.30μg/kg dose.  Specifically, 
they stated “The bolus administration of dexmedetomidine in this [0.30ug/kg] dose was 
safe, and it did not lead to an increased incidence of side effects.  However, more studies 
are needed to determine both the efficacy and safety of dexmedetomidine using either in 
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different types of surgery or at larger doses” (Ibacache, Muñoz, Brandes, & Morales, 
2003, p. 63). 
An international research investigation performed at the Erciyes University in 
Kayseri, Turkey enrolled 60 subjects aged of three to seven who underwent 
adenotonsillectomy with a sevoflurane based volatile general anesthesia.  The subjects 
were divided into two groups.  One group received 0.5μg/kg IV dexmedetomidine diluted 
in 5ml NaCL 0.9% and the second group received a 5ml sodium chloride (NaCL) 0.9% 
IV placebo.  “Times to emergence and extubation in the dexmedetomidine group were 
significantly longer than the placebo group.  The agitation and pain scores in the 
dexmedetomidine group were better than placebo group (p < 0.05 for each).  The 
incidence of severe agitation, and severe pain were significantly low in the 
dexmedetomidine group” (Guler et al., 2005, p.764).   A particularly interesting and 
unique finding of this study was a lower frequency of airway problems with subjects in 
the dexmedetomidine group.  It was unknown whether this observation was due to a 
decreased degree of laryngeal stimulation brought about by the sedative and analgesic 
effects of dexmedetomidine or whether it was simply observed to have occurred by 
chance.   
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Chapter III 
 
Materials and Methods 
 The objectives of this study were to measure the effects of pre-operative orally 
administered dexmedetomidine compared to orally administered midazolam for children 
aged one to six years having dental restoration and possible dental extractions in 
relationship to:  (1) parental separation and acceptance of an anesthesia mask in 
association with the induction of anesthesia, and (2) the incidence and severity of 
emergence delirium upon emergence of anesthesia. The Pediatric Anesthesia Emergence 
Delirium Scale (PAEDS) was utilized to collect data regarding emergence delirium in all 
of the enrolled subjects.  This instrument is a five-question survey that allowed the 
researcher to distinguish between normal post-anesthesia recovery and post-anesthesia 
emergence delirium. 
Operational Definitions 
  The following section identifies the operational definitions that were used 
throughout the remainder of this author’s manuscript. 
1. Acceptance of Mask tool –A tool used to measure the ease of acceptance of 
the anesthetic mask. 
Appendix A contains specific definitions 
2. American Society of Anesthesiologists (ASA) – The American Society of 
Anesthesiologists is a professional association involved in educational 
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research and scientific endeavors for physician members and others with the 
goal of raising and maintaining the standards of the medical practice of 
anesthesiology and improves the care of the patient. 
3. ASA Physical Status Classification (PSC) – Assessment used to predict the 
safety of patients receiving anesthesia based on their physical status at the 
time of surgery. 
Appendix B contains specific definitions.  
4. Dental Restoration – The application of caps and or crowns to teeth with 
dental carries as well as basic dental cleaning. 
5. Emergence Delirium (ED) – A mental disturbance during the recovery from 
general anesthesia consisting of hallucinations, delusions and confusion 
manifested by moaning, restlessness, involuntary physical activity, and 
thrashing about in bed. 
6. Endotracheal Anesthesia – General anesthesia that is delivered to the lungs 
through the trachea via an endotracheal tube. 
7. Endotracheal tube – A plastic or rubber tube that is inserted through the nose 
or mouth into the trachea, by which oxygen, anesthetic gases, and/or volatile 
anesthetics are delivered. 
8. General Anesthesia – The loss of consciousness and sensation throughout the 
entire body following the administration of any combination of medications 
and agents via an intravenous and/or pulmonary route.           
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9. Parental Child Separation tool –A tool used to measure the ease of separation 
of a child from his/her parents and/or legal guardians. 
Appendix C contains specific definitions 
10. Pediatric Anesthesia Emergence Delirium Scale (PAEDS) – A valid and 
reliable instrument designed to measure the presence and severity of 
emergence delirium in children during the post-anesthesia postoperative 
period. 
Appendix D contains specific definitions. 
Research Design, Sample, and Setting 
 After approval was obtained from the Investigational Review Board (IRB) 
committees of the host clinical research site and The University of Tennessee, Knoxville, 
this randomized, double-blind pilot study was conducted with 41 subjects, consisting of 
both males and females, aged one to six years having dental restoration and/or dental 
extractions under general anesthesia at a southeastern united states pediatric specialty 
hospital.  All subjects met the criteria of the ASA physical status classification (PSC) I or 
ASA PSC II (Appendix B).   
Upon scheduling a child for a dental restoration and possible extraction, parent(s) 
or legal guardian(s) were given an information sheet about the research study and 
provided a study informed consent form with a request to review prior to the day of 
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surgery (Appendix E).   In addition, the parents or legal guardians were asked to consider 
allowing their child to participate in the investigation as a study subject. On the day of 
surgery, the parent(s) or legal guardian(s) were again approached by the staff 
anesthesiologist about participating as a subject in the research study. If the parent or 
legal guardian indicated an interest in participation, the purpose of the study was 
explained in depth by the anesthesiologist who was also a principal investigator. Parent(s) 
or legal guardian(s) were informed that they were consenting to participation in a double-
blinded study comparing the incidence of emergence delirium between the study groups. 
The anesthesiologist answered any questions the parent(s) or legal guardian(s) had about 
the study. If the parent(s) or legal guardian(s) subsequently agreed to allow their child to 
participate in the study, the consent form was presented by a research team member for 
review and signature. The subject being consented for participate was assigned to one of 
two the study groups (i.e. oral dexmedetomidine or oral midazolam) based on random 
assignment as prelisted on the consent form. 
Inclusion and Exclusion Criteria 
 All subjects met the following inclusion criteria in order to be enrolled in the 
study: 
1. Both males and females  
2. Between the ages of one to six years  
3. Requiring elective dental restoration and possible extractions   
4. Requiring general endotracheal anesthesia 
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5. ASA PSC I or ASA PSC II  
The exclusion criterion included the following: 
1. Not meeting inclusion criteria  
2. Co-existing disease states 
3. Known allergies to midazolam, dexmedetomidine, clonidine, 
benzodiazepines, and/or red dye  
4. Evidence or diagnosis of developmental delay and/or mental 
retardation  
5. History of emergence delirium  
6. Known previous negative reactions (per history) to a previous 
anesthesia administration   
7. Parents or guardians without access to a telephone  
8. No parent or legal guardian present to give informed consent 
Informed Consent 
In the dental office, upon scheduling a child for a dental restoration with or 
without possible extraction under general anesthesia, parent(s) or legal guardian(s) were 
given for review, a copy of the informed consent along with an information sheet 
describing the research study (Appendix F).  The dentist or the office personnel provided 
these items from a pre-printed supply delivered by the researchers.   Parents met with the 
dental surgeon approximately one month prior to surgery, and so initial solicitation of 
subjects occurred considerable prior to the request for participation and subject enrolment 
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procedures.  On the day of surgery, the researcher and anesthesiologist discussed the 
study with the parent(s) or legal guardian(s).  The purpose of the study was explained by 
the anesthesiologist in the presence of the research nurse.  Parent(s) or legal guardian(s) 
were informed that they were consenting to participation by their child in a double-
blinded study comparing the incidence of emergence delirium between the two study 
groups.  The anesthesiologist and the research nurse used terms understandable to the 
subject’s parent(s) or legal guardian(s) and answered any questions about the study.  
They were given sufficient time to consider participation in the study.  Parent(s) and legal 
guardian(s) were notified that, if they chose not to participate in the study, they would not 
be treated any differently than if they agreed to participate.  If the parent agreed to 
participate in the study, the consent form was presented by the research team member for 
parent or legal guardian signature.  Those parents or legal guardians who agreed to allow 
their children to participate in the study were notified that at any point in time they could 
withdraw their child from the study without any detriment to the care or well being of 
their child.  It was at this time that demographic data was obtained for each subject, and 
entered in the data sheet designed for use in the study (Appendix G). 
Study Protocol 
 The subjects were randomly assigned to the study groups based on the prelisted 
consent forms, which were prepared in advance of the initiation of the study.  The 
specific group assignments were determined through the use of a computer generated 
randomization table. 
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  Once randomized, but prior to the administration of any medications, the 
pharmacy was notified by a member of the research team of the group assignment so 
medication safety could be evaluated for each subject. The subject’s name, study number, 
and group number were kept in a pharmacy log. Pharmacy provided a supply of pre-
operative oral medications labeled ED Study Drug-A and ED Study Drug-B.  The 
following pre-operative dosing protocol (Appendix H) was utilized on all subjects: 
1. Determine the study drug the patient was to receive: Patients whose study 
consent form had A at the top received the study drug labeled A.  Those 
subjects whose consent forms had a B on the top of the form received the 
study drug labeled B. 
2. The dose of the study drug, dexmedetomidine, was mixed into a solution at 16 
micrograms/milliliter and was dosed at 4 micrograms/kilogram.  The resulting 
milliliter dose was 0.25 milliliters/kilogram with a maximum dose of 10 
milliliters. 
3. The dose of the study drug, midazolam, will remain at manufacturer’s strength 
of 2 milligrams/milliliter and was dosed at 0.5 milligrams/kilogram.  The 
resulting milliliter dose was 0.25 milliliters/kilogram with a maximum dose of 
10 milliliters. 
4. The bottles with the medications were labeled ED study Group A or ED study 
Group B and were kept in the Omnicell. 
5. Study patients were prohibited from receiving atropine or any other type of 
anti-cholinergic medications. 
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6. The pharmacy staff was to disclose the identity of the study drug when all data 
had been collected, the study was completed or closed, and if any reaction 
occurred that was suspected to be an adverse reaction to the study drug.  
Should adverse reaction have occurred, the study personnel were to be 
notified immediately, and the subject was to be treated symptomatically as 
necessary   
Regardless of the utilization of study drug A or study drug B, the syringe that contained 
the drug was opaque, the same size, the same volume, and had no identifiable features.  
Both study drug A and study drug B were identical in color and texture so as to be 
unidentifiable between them. 
 The following protocol was utilized for all subjects: 
1. At time of separation of subject from parent(s) and/or legal guardian(s), the 
researcher evaluates the subject by the Parental Child Separation Tool using a 
four-point scale (Appendix C). 
2. The researcher follows the subject into surgery where the Mask Acceptance 
Tool is used to score the subject (Appendix A). 
  The following anesthesia protocol (Appendix I) was utilized on all subjects: 
1. Induction is preformed via mask with sevoflurane 6% in oxygen 50%, and 
nitrous oxide 50%. 
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2. Volatile anesthesia agents are to be changed to isoflurane at a range of 1.5% 
to 0.8% for maintenance of acceptable surgical anesthesia as soon as practical 
following induction. 
3. Spontaneous ventilation should be maintained as soon as practical and 
possible. 
4. If positive pressure ventilatory support is required, muscle relaxant is to be 
avoided, if possible. 
5. Avoid medications with anti-cholinergic properties: atropine, glycopyrrolate, 
meperidine, pancuronium bromide etc. (to avoid confusion between 
emergence delirium and central anticholinergic syndrome) 
6. Maintain acceptable anesthetic depth with isoflurane between a range of 1.5 % 
and 0.8%, oxygen 50% and nitrous oxide 50%. 
7. Administer ondansetron 0.2 mg/kg and decadron 0.25 mg/kg to all subjects as 
soon as possible after the induction of anesthesia for anti-emesis. 
8. Administer fentanyl 1-2 micrograms/kg for narcotic analgesia. 
9. Request dental surgeon use local anesthetic blocks for all root canals and 
extractions when acceptable and record the administration on the anesthesia 
record. 
10.  Abandon any of the above guidelines/restrictions if needed for safety of the 
patient and make study personnel aware of the change in the standard 
protocol. 
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11. After completion of the surgical procedure, anesthesia is discontinued, 100% 
oxygen is to be given to the subject, and subject is to be extubated per criteria 
(Appendix J).  
12. Following extubation, the subject is to be taken to the post-anesthesia 
recovery room where they will be observed for up to an hour and be evaluated 
by using the Pediatric Anesthesia Emergence Delirium Scale (PAEDS) tool 
(Appendix D) measuring for emergence delirium. 
The various protocols stated above were created in order to act as a guide for every step 
of the research process.  These protocols protect not only the researcher, but also more 
importantly the subjects. 
Instrumentation 
 The parental separation measurement tool (Appendix C) is a four-point scale used 
to measure the subject’s willingness to separate from the parent(s) and/or legal 
guardian(s).  Children with scores of one or two on the for-point scale were considered to 
have had an acceptable separation from the parents immediately prior to the initiation of 
the surgical procedure; those with scores of three or four were considered to have had 
difficult pre-procedure parental separations.  This tool was used in a previous study 
(Weldon, 1992) where it demonstrated an acceptable reliability and validity for the 
purpose it was utilized.  However, this tool has not been validated or evaluated for its 
psychometric soundness.  Since no other instruments were available for this purpose, and 
since instrument construction was beyond the scope of this author’s investigation, the use 
of this instrument was justified and it was utilized with its limitations deemed acceptable.  
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 The mask acceptance tool (Appendix A) is also a four-point scale used to measure 
the subject’s willingness to accept the anesthetic mask from the nurse anesthetist once in 
the operating room.  Children with scores of one or two on the four point scale are 
designated as having had a “satisfactory” acceptance of the anesthesia mask; scores of 
three or four were considered “unsatisfactory” (Shukrey 2005, & Weldon, 1992). No 
psychometric data are available for this tool either, however, since no other instruments 
were available for this purpose, and since instrument construction was beyond the scope 
of this author’s investigation, this instrument was utilized and its limitations deemed 
acceptable. 
The PAEDS (Appendix D) is a five-question tool that was used to measure the 
presence of emergence delirium during each possible episode. A score of zero to 20 is 
possible. When the data are analyzed, a PAEDS score >10 will be considered emergence 
delirium (ED). As determined by Sikich and Lerman (2004), the coefficient alpha for 
internal consistency reliability has been reported as .89 with an interobserver reliability of 
.84 (95% CI, .76-.90). Construct validity was evaluated by six content experts and tested 
on 100 children to determine correlation between scale scores and factors such as age, 
time to awakening, and clinical judgment by caretakers. In addition to the scale score, 
several other items were recorded such as time of pre-operative medication, time 
operation began and ended, time anesthesia began and ended, time extubated, time 
entered and left PACU and opioids given in PACU. 
Data Analysis 
 A chi-square was used to determine differences between the control and 
experimental groups with respect to separation anxiety and acceptance of mask.  
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Independent t-test statistical procedures were used to determine differences between the 
occurrence and severity of emergence delirium in the experimental and control groups.  
Assumptions 
 The basic assumptions made regarding this study are as follows: 
1. The PAEDS tool is a predictive and accurate instrument for measuring 
pediatric emergence delirium following general endotracheal anesthesia. 
2. The random sample was representative of the population. 
3. The Parental Child Separation tool is a predictive and accurate instrument for 
measuring parental separation anxiety. 
4. The Mask Acceptance tool is a predictive and accurate instrument for 
measuring the willingness to accept the anesthetic mask.  
Study Limitations 
1. There might possibly have been unanticipated individual varying responses to 
the prescribed anesthetic plan. 
2. Both midazolam and dexmedetomidine were mixed in cherry syrup, which 
could have potentially changed its makeup in some unknown manner. 
3. Neither the Parental Child Separation tool nor the Mask Acceptance tool has 
undergone statistical testing for external validity or reliability. 
4. Neither the Parental Child Separation tool nor the Mask Acceptance tool have 
been statistically tested and validated to accurately and reliably measure 
parental separation anxiety or willingness to accept the anesthetic mask. 
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Specific Risks and Protection Measures for Human Subjects  
The most common side effects from dexmedetomidine include nausea, atrial 
fibrillation, bradycardia, hypertension, hypotension, and supraventricular tachycardia, 
fever and vomiting. The most common side effects of midazolam include retrograde 
amnesia, headache, excessive sedation, confusion, hypotension, blurred vision, nausea, 
vomiting, and coughing 
 Each research team member was a nurse or graduate student nurse and 
accompanied the subject through the process. No patient identifiers were used in the 
publication of this study. All research team members signed a confidentiality form. 
The approximate cost of one dose of midazolam is 1/3 the approximate cost of the 
dexmedetomidine. This increased cost may have been offset because less pain medicine 
might have been needed after the subject received dexmedetomidine. 
Study Benefits 
 The patients in the study group may have less emergence delirium and may 
experience less pre-operative anxiety as evidenced by a lower score on the PAEDS tool. 
The subjects receiving dexmedetomidine may achieve better pain control and therefore 
receive less opioid, thereby decreasing some of the additional cost.  It is hoped that the 
study will indicate that dexmedetomidine reduces the incidence of emergence delirium 
without causing any increase in observed negative side effects. If so, it could be utilized 
in the future as a pre-operative medication to ease the occurrence of ED, and so all of the 
documented negative effects of emergence delirium.  Consequently, everyone who 
undergoes anesthesia could potentially benefit from the findings of this investigation. 
Participants of this study received no compensation or incentive to participate in this 
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study, and the investigators were not paid to conduct this research protocol.  Therefore, 
no monetary gain by either subjects or researchers was a benefit of the work conducted as 
part of this study.  
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Chapter IV 
 
Results 
 
There were two objectives of this pilot study.  The first objective was to measure the 
effects of pre-operative orally administered dexmedetomidine as compared to orally 
administered midazolam in relation to parental separation.  The second objective was to 
evaluate the acceptance of an anesthesia mask and to measure the incidence and severity 
of emergence delirium in children aged one to six years having dental restoration with or 
without dental extractions who were administered either oral dexmedetomidine or oral 
midazolam pre-operatively. 
The questions this researcher sought to answer were:   
1. Does orally administered dexmedetomidine promote better parental separation 
and acceptance of an anesthesia face mask as compared to orally administered 
midazolam in children aged one to six years having dental restoration, with or 
without dental extractions? 
2. Does orally administered dexmedetomidine affect the incidence and severity 
of emergence delirium in children aged one to six years having dental 
restoration, with or without dental extractions, as compared to orally 
administered midazolam for the same population undergoing the same 
procedures? 
In search of the answers to the research questions posed, this author addressed the null 
hypothesis:   
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There will be no difference in the incidence or severity of emergence delirium as 
measured by the Pediatric Anesthesia Emergence Delirium Scale (PAEDS) in 
subjects aged one to six years who receive oral dexmedetomidine compared to 
subjects aged one to six years who receive oral midazolam as an anesthetic pre-
medication prior to dental restoration, with or without dental extractions. 
Descriptive Statistics 
The study population consisted of 41 subjects, composed of both males and 
females age one to six years having dental restoration and/or dental extractions under 
general anesthesia at a southeastern United States pediatric specialty hospital.  All 
subjects met the criteria of the ASA physical status classification (PSC) I or ASA PSC II 
(Appendix B).  Group A consisted of 19 subjects (46.3%) and Group B consisted of 22 
subjects (53.7%).  Gender distribution included 21 males (51.2%) and 20 females 
(48.8%) as seen in Table 1 and Figure 1.  Racial distribution of the study subjects, as 
identified in Table 2 and Figure 2, was as follows: Caucasian 27 (65.9%), African 
American 9 (22.0%), and Hispanic 5 (12.2%).  While obtaining the subject’s medical 
history, the parents or guardians were asked if the subjects were currently taking any 
medications on a regular basis.  It was reported that thirty-one subjects (75.6%) did not 
take any medication on a regular basis while ten subjects (24.4%) were reported to take 
medications on a regular basis (Table 3, Figure 3). 
  
 
 
 
Table 1:  Gender Analysis 
  
 
  Frequency Percent
Valid 
Percent 
Cumulative 
Percent 
Valid Male 21 51.2 51.2 51.2
  Female 20 48.8 48.8 100.0
  Total 41 100.0 100.0  
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   Figure 1: Gender Description 
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Table 2:  Race Analysis 
 
 
  Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid Caucasian 27 65.9 65.9 65.9 
  African 
American 9 22.0 22.0 87.8 
  Hispanic 5 12.2 12.2 100.0 
  Total 41 100.0 100.0   
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    Figure 2:  Race Description 
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 Table 3:  Medication Frequency 
 
 
  Frequency Percent
Valid 
Percent 
Cumulative 
Percent 
Valid No 31 75.6 75.6 75.6 
  Yes 10 24.4 24.4 100.0 
  Total 41 100.0 100.0   
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  Figure 3:  Description of Medication Frequency 
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All subjects were randomly assigned to the study groups based on the prelisted 
consent forms (Appendix F), which were prepared in advance of the initiation of the 
study.  The specific group assignments were determined through the use of a computer 
generated randomization table.  Group A, consisting of 46.3% of the study’s subjects, 
received 0.5 mg/kg of orally administered midazolam.  Group B, consisting of 53.7% of 
the study’s subjects, received 4mcg/kg of orally administered dexmedetomidine.   
Parental Separation 
With respect to the first question, which addressed whether subjects receiving 
orally administered dexmedetomidine exhibited better parental separation and acceptance 
of an anesthesia face mask as compared to oral midazolam, all 41 subjects were 
administered the Separation From Parents tool (Appendix C), a four-point scale used to 
measure the subject’s willingness to separate from the parent(s) and/or legal guardian(s).  
Recalling the study design, subjects with scores of one or two on the four-point scale 
were considered to have had an acceptable separation from the parents immediately prior 
to the initiation of the surgical procedure; those subjects who were scored three or four 
were considered to have had difficult pre-procedure parental separations. 
 Group A had a total of 19 subjects, 16 (84.2%) of which demonstrated easy 
separation from parents based on observations and scoring on the Separation From 
Parents tool.  The other three subjects in group A scored in each of the other three 
categories of the tool, for a total of 5.3% of the group A population in each category.  
Group B consisted of 22 subjects.  Fourteen subjects (63.6%), of the group population 
experienced easy separation.  Four of the subjects in Group B (18.2%), scored a two on 
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the tool, three subjects, 13.6%, scored a three, and one subject, 4.5%, scored a four, table 
4.  See appendix C for tool scoring.  
After performing a Chi-Square test on the data obtained through the use of the 
Parental Separation Tool (Table 5), it was determined that the Chi-Square was not the 
best test for this data as calculation resulted in a Pearson Chi-Square value of only 2.728.  
Consequently, this would have left only six cells (75%) having an expected count of less 
than five, with the minimum expected count being 93%.  Therefore, in conjunction with a 
statistical consultant, it was determined that the data needed to be transformed into two 
groups.  Group one was comprised of subjects demonstrating: Easy Separation, scoring a 
one. Group two was comprised of both: Whimpers + Cries but Not Clinging and Crying 
and Clinging, scoring two, three or four. 
The number of subjects for Group A and Group B remained unchanged, as well as 
the number of subjects with easy separation score of one.  The number of subjects that 
scored a two, three, or four, in Group A totaled three (15.8%).  Group B had a total of 
eight subjects (36.4%) that scored a two, three, or four (Table 6).  This resulted in a total 
of 30 (73.2%) of the subjects being assigned to the first group as the result of being 
scored a one, and eleven (26.8%) of the subjects being assigned to the second group as 
the result of being scored a two, three, or four.  This rearrangement allowed a new chi-
square evaluation to be performed.  The results of this assessment are contained in Table 
7.  A Pearson Chi-Square p-value of 0.138 and a Fishers Exact Test p-value of 0.173 
were also obtained for this data.  Based upon these outcomes, it was determined that there 
was no statistical significant difference in measured amount of distress related to  
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Table 4:  Parental Separation Crosstabulation 
 
   
Describe the separation of the child from the 
parents Total 
    
Easy 
Separation 
Whimpers 
but is 
easily 
reassured 
not 
clinging to 
parent 
Cries and 
can not be 
easily 
reassured, 
but not 
clinging to 
parent 
Crying and 
clinging to 
parents 
Easy 
Separation 
Group A Count 16 1 1 1 19 
    % within 
Group 84.2% 5.3% 5.3% 5.3% 100.0% 
  B Count 14 4 3 1 22 
    % within 
Group 63.6% 18.2% 13.6% 4.5% 100.0% 
Total Count 30 5 4 2 41 
  % within 
Group 73.2% 12.2% 9.8% 4.9% 100.0% 
 
 
 
                       Table 5:  Parental Separation Chi-Square Test 
  
 
  Value df Asymp. Sig. (2-sided) 
Pearson Chi-Square 2.728(a) 3 .435 
Likelihood Ratio 2.888 3 .409 
N of Valid Cases 41   
 
a)  6 cells (75.0%) have expected count less than 5. The minimum expected count is  
     0.93. 
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Table 6:  Parental Separation Re-Crosstabulation 
 
 
 
    Parent Separation Problems  
    
No  
(parent separation 
=1) 
Yes  
(parent separation 
=2,3,4) Total 
Group A Count 16 3 19 
    % within 
Group 84.2% 15.8% 100.0% 
  B Count 14 8 22 
    % within 
Group 63.6% 36.4% 100.0% 
Total Count 30 11 41 
  % within 
Group 73.2% 26.8% 100.0% 
 
 
 Table 7:  Parental Separation Chi-Square Test after Re-Crosstabulation 
 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 2.198(b) 1 .138   
Continuity 
Correction(a) 1.275 1 .259   
Likelihood Ratio 2.272 1 .132   
Fisher's Exact Test    .173 .129 
N of Valid Cases 41     
 
a) Computed only for a 2x2 table 
b) 0 cells (0.0%) have expected count less than 5.  The minimum count is 5.10. 
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separation from parents between subjects in Group A who received orally administered 
midazolam as compared to the measured distress of subjects in Group B who received 
orally administered dexmedetomidine.  It was not possible to determine if the observed 
differences between the subjects in each of these two groups was the result of chance 
rather than the result of the experimental influence introduced by the researchers.   
 There was one interesting finding in the parental separation data that required 
further analysis.  Upon further review of the data, as seen in table 8, it was noticed that 
seven out of 11 (63.6 %) of the male subjects in group B (dexmedetomidine group) had 
parental separation scores two, three or four.  This finding was contrasted with only one 
out of 10 (10%) of the male subjects in group A (midazolam group) experiencing parental 
separation problems.  Although there were only 21 male subjects in the study, eight 
subjects in group A and group B combined demonstrated parental separation scores of 
two, three or four.  As detailed in Table 9, the Pearson Chi-Square p-value comparing 
group A (midazolam group) and group B (dexmedetomidine group) was 0.11.  The 
Fishers Exact Test was 0.24, which is less than 0.05, suggesting that there is statistical 
significance between the two groups.  The next step was to assess a risk estimate between 
group A and group B.  Table 10 shows that the male subjects in group B 
(dexmedetomidine group) were 15.75 times more likely to experience parental separation 
problems than the males in group A, midazolam group.  This finding was not a part of 
this author’s original research investigation, but proved to be interesting and supported 
the need for further research with a larger study population. 
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Table 8:  Parental Separation Gender Crosstabulation 
Gender     Parent Separation Problems Total 
      
Yes 
(parental 
separation
=2,3,4) 
No (parental 
separation=1) 
Yes (parental 
separation =2,3,4) 
Male Group B Count 7 4 11 
      % within 
Group 63.6% 36.4% 100.0% 
    A Count 1 9 10 
      % within 
Group 10.0% 90.0% 100.0% 
  Total Count 8 13 21 
    % within 
Group 38.1% 61.9% 100.0% 
Female Group B Count 1 10 11 
      % within 
Group 9.1% 90.9% 100.0% 
    A Count 2 7 9 
      % within 
Group 22.2% 77.8% 100.0% 
  Total Count 3 17 20 
    % within 
Group 15.0% 85.0% 100.0% 
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Table 9:  Parental Separation Problems Gender Chi-Square Test 
Gender   Value df 
Asymp. 
Sig. (2-
sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 6.390(b) 1 .011   
Continuity Correction(a) 4.318 1 .038   
Likelihood Ratio 6.988 1 .008   
Fisher's Exact Test    .024 .017 
Linear-by-Linear 
Association 6.086 1 .014   
Male 
N of Valid Cases 21     
Pearson Chi-Square .669(c) 1 .413   
Continuity Correction(a) .036 1 .850   
Likelihood Ratio .672 1 .412   
Fisher's Exact Test    .566 .421 
Linear-by-Linear 
Association .636 1 .425   
Female 
N of Valid Cases 20     
 
(a)  Computed only for a 2x2 table 
(b)  2 cells (50.0%) have expected count less than 5. The minimum expected count is 3.81. 
(c)  2 cells (50.0%) have expected count less than 5. The minimum expected count is 1.35. 
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Table 10:  Parental Separation Problems Gender Risk Estimate 
 
Gender   Value 95% Confidence Interval 
    Lower Upper Lower 
Male Odds Ratio for Group (B / A) 
15.750 1.424 174.246 
  For cohort Parent Separation Problems  
 Yes (parental separation =2,3,4) 6.364 .940 43.073 
  For cohort Parent Separation Problems  
 No (parental separation =1) .404 .180 .907 
  N of Valid Cases 21   
Female Odds Ratio for Group (B / A) 
.350 .026 4.654 
  For cohort Parent Separation Problems  
 Yes (parental separation =2,3,4) .409 .044 3.816 
  For cohort Parent Separation Problems  
No (parental separation =1) 1.169 .787 1.737 
  N of Valid Cases 20   
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Mask Acceptance 
 The Mask Acceptance Tool (Appendix A) is also a four-point scale used to 
measure the subject’s willingness to accept the anesthetic mask from the nurse anesthetist 
once in the operating room.  Consistent with the study design, the induction of anesthesia 
with each subject was preformed via face mask utilizing inhaled sevoflurane 6% in 
combination with 50% oxygen and 50% nitrous oxide.  Subjects were observed to 
determine their resistance to accepting the anesthesia as delivered by face mask.  Subjects 
observed and evaluated to have scored one or two on the four point scale were designated 
as having had a “satisfactory” acceptance of the anesthesia mask; scores of 3 or 4 were 
considered “unsatisfactory” (Shukrey 2005, & Weldon 1992). 
Mask acceptance scores from each subject group A and B, were divided into two 
groups: (1) Excellent or Good and (2) Fair or Poor.  In group A, 15 of 19(78.9%) of all 
subjects were evaluated to have displayed either good or excellent relative to anesthesia 
mask acceptance.  In group B, 15 of 22 (68.2%) of all subjects were evaluated to have 
had scores of good or excellent relative to anesthesia mask acceptance.  As identified in 
Table 11, 73.2% of the study’s subjects were scored in the Excellent or Good range and 
26.8% of the subjects scored in the Fair or Poor range.  A Chi-Square analysis was 
performed on the Mask Acceptance scores (Table 12).  A Pearson Chi-Square score p-
value of 0.438 and a Fishers Exact Test p-value of 0.499 were calculated on this data.  
Results of this analysis evidenced no significant difference in acceptance of mask 
between subjects in Group A, who received orally administered midazolam, and subjects 
in Group B, who received orally administered dexmedetomidine.  Once again, the 
evaluated  
 41
 
Table 11:  Mask Acceptance Crosstabulation 
 
 
    
Subject's Acceptance of 
Mask Total 
    
Excellent or 
Good Fair or Poor Excellent or Good 
Group A Count 15 4 19 
    % within 
Group 78.9% 21.1% 100.0% 
  B Count 15 7 22 
    % within 
Group 68.2% 31.8% 100.0% 
Total Count 30 11 41 
  % within 
Group 73.2% 26.8% 100.0% 
 
 
 
Table 12:  Mask Acceptance Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact 
Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square .602(b) 1 .438   
Continuity 
Correction(a) .178 1 .673   
Likelihood Ratio .609 1 .435   
Fisher's Exact Test    .499 .338 
N of Valid Cases 41     
a)  Computed only for a 2x2 table 
b)  0 cells (.0%) have expected count less than 5. The minimum expected count is 
5.10. 
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results did not support the elimination of chance, rather than scientific manipulation, as 
the contributing factor resulting in the observed findings. 
Emergence Delirium 
The second question this researcher sought to answer was:  Does orally 
administered dexmedetomidine affect the incidence and severity of emergence delirium 
in children aged one to six years having dental restoration, with or without dental 
extractions, as compared to orally administered midazolam for the same population 
undergoing the same procedures?  To answer this question we administered the Pediatric 
Anesthesia Emergence Delirium Scale to the subjects.  All 41 subjects were administered 
the test, see table 13.  Group A, 19 subjects, had a mean score of 7.42 and group B, 21 
subjects, had a mean score of 5.62.  See Appendix D for tool and scoring information.  
There was a standard deviation in group A of 5.210 and in group B of 5.861.  As seen in 
Figure 4, there was a slight skewing of the data, particularly in group B.  The standard of 
error mean for group B was only 1.279 and group A was even lower with a mean of only 
1.195.  Even though group A had a higher mean PAEDS score, more testing was needed 
to determine whether or not the data was statistically significant.   
A Levene’s Test for equality of variances and a T-test for equality of means was 
performed on the data (see Table 14).  Subsequently, equal variances were indicated by 
these results because Levene’s Test for equality p-value was determined to be 0.877.  
After performing the independent t-test for equality of means between group A and group 
B, we found the p-value to be 0.313.  This result supported the conclusion that there was  
 
Table 13:  PAEDS Group Statistics 
 Group N Mean 
Standard 
Deviation Standard Error Mean 
Total PAEDS 
Score 
A 19 7.42 5.210 1.195 
  B 
21 5.62 5.861 1.279 
 
 
 
 
 
8
6
4
2
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20151050
8
6
4
2
0
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A
B
Frequency 
  
  Figure 4:  Description of Total PAEDS Score 
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Table 14:  PAEDS Levene’s Test and Independent t-test 
 
Levene’s Test 
for Equality 
of Variances 
   
F Sig. T df Sig. 
(2-
tailed)
Mean 
difference 
Std. Error 
Difference 
Equal 
variance 
assumed 
0.24 0.877 1.023 38 0.313 1.802 1.761 Total 
PAEDS 
Score 
Equal 
variance 
not 
assumed 
  1.029 37.992 0.310 1.802 1.751 
 (Assume equal variances because Levene’s Test for Equality p-value = 0.877) 
 
no statistical significant difference in the mean PAEDS scores between group A and 
group B, which could not be attributed to chance.   
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Chapter V 
 
Discussion 
 
 
According to Voepel-Lewis, Malviya, and Tait (2003), patients experiencing 
emergence delirium may exhibit one or more of the following signs and symptoms; 
nonpurposeful restlessness and agitation, thrashing, crying or moaning, disorientation, 
and incoherence.  This phenomenon has been considered a common post-anesthetic 
problem in children and adults since its description in the literature in 1960.  Although 
the exact cause of emergence delirium is not known, the observations made of pediatric 
patients emerging from anesthetics in this study were consistent with the literature, which 
has described some association between rapid emergence and awakening from anesthesia 
in a foreign environment and a higher frequency of emergence delirium (Cole, Murray, 
McAllister, & Hirshberg, 2002).   
In this pilot study of 41 subjects, the investigator sought out to answer two unique 
questions: 
1. Does orally administered dexmedetomidine promote better parental separation 
and acceptance of an anesthesia face mask as compared to orally administered 
midazolam? 
2. Does orally administered dexmedetomidine lessen the incidence and severity 
of emergence delirium in children 1-6 years having dental restoration, with or 
without dental extractions, as compared to orally administered midazolam? 
In search of the answers to the research questions posed, this author addressed the 
null hypothesis:   
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There will be no difference in the incidence or severity of emergence delirium as 
measured by the Pediatric Anesthesia Emergence Delirium Scale (PAEDS) in 
subjects aged one to six years who receive oral dexmedetomidine compared to 
subjects aged one to six years who receive oral midazolam as an anesthetic pre-
medication prior to dental restoration, with or without dental extractions.  
Although the size of this pilot study did not provide definitive answers to the 
research questions under investigation, the data collected did provide the groundwork for 
a larger future study.  While the observations recorded as a result of this investigation 
were not generalizable to larger populations because of the small number of subjects in 
the pilot, the results observed were clinically significant and support the need for further 
investigation into the factors surrounding emergence delirium prevention in the pediatric 
population.   
Confounding Variables 
 Several confounding variables were identified as the research study was 
conducted.  These variables added to the difficulty in obtaining subject participation, data 
collection, and contributed to the overall consumption of time that this study required.  
The first variable was that the youngest patients were usually scheduled for surgery first 
on any particular day.  This made patient acquisition only possible in the mornings.  
Having more surgeons involved with the study increased potential subject pool and 
required increasing the number of research assistants to alleviate this problem.  This 
increased the potential for variation in subject scoreing and added threat to the validity of 
observed results, although this was considered a negligible threat.   
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Second, there was only one Anesthesiologist available to screen all patients 
preoperatively and to provide witness to informed consent required for subject enrollment 
and participation.  This made it impossible to obtain consent on the first patient scheduled 
each day, as well as difficult at times to obtain consent at other periods through the day 
when the anesthesiologist was needed elsewhere for patient care.  Having one 
anesthesiologist specifically dedicated to screening and witnessing of informed consent 
for the study would have greatly reduced or alleviated this variable.   
Another variable that was identified in retrospect was related to the role of the 
research site pharmacy.  Once a subject was consented and enrolled in the study, their 
information was faxed to pharmacy.  It was only then that the research protocol specific 
medication was customized for each subject by weight and for their specific randomized 
study group.  This process took upward of thirty minutes for each subject.  The subject’s 
preoperative medication was to be given upon the operating rooms call, thirty minutes 
before transport.  Consequently, numerous would not show up on time and they would 
need to receive their preoperative medication immediately.  These occurrences made the 
enrollment of many subjects impossible.  Having a research dedicated pharmacist would 
have significantly decreased the waiting period encountered by researchers to receive the 
study drug preparations.  Unfortunately, nothing could be done about the patient’s 
tardiness and this factor was not anticipated by any of the members of the researcher’s 
team.   
Lastly, there were times when the data collector was with one subject while 
another subject needed to be screened and consented.  Due to the lack of data collectors, 
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there were multiple subjects that the researchers were not able to provide an opportunity 
to participate in the study.  Once again, while additional research assistants might have 
created additional confounding issues, having more research assistants would have 
helped to alleviate this fairly significant obstacle encountered by the research team. 
Limitations 
 This study was specifically designed to eliminate several outside variables such as 
age, ASA classification, co-morbidities, type of operation, type of induction and 
maintenance of general anesthesia, intraoperative and postoperative pain control, the 
avoidance of anti-cholinergic medications, dental surgeon use of local anesthetic blocks 
for all root canals and extractions when acceptable, and the application of all tools by a 
trained research team member.  Despite best efforts, there were some limitations that 
were identified for this study.  First, there might possibly have been unanticipated 
individual varying responses to the prescribed anesthetic plan.  However, this is always a 
possibility whenever human subjects are utilized in any research protocol.  Next, both 
midazolam and dexmedetomidine were mixed in cherry syrup, which could have 
potentially changed the pharmacodynamics in some unknown manner; however this is 
only postulated and not supported by any of the scientific literature currently available to 
this author.  Third, neither the Parental Child Separation tool nor the Mask Acceptance 
tool has undergone statistical testing for external validity or reliability, nor have they 
been statistically tested and validated to accurately and reliably measure parental 
separation anxiety or willingness of subjects to accept the anesthetic mask.  Lastly, the 
greatest limitation to this study was its subject pool size.  With only 41 subjects, 
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generalizations are unable to be made to the general population.  This study was, 
however, able to bring to light certain data that justifies further future research 
investigation with a larger study population to better allow greater generalizability 
beyond the confines of the pilot study subjects. 
Strengths 
 The strengths of this study included the fact that it was a double blinded and 
randomized study.  The code, which protected the pharmacologic intervention, was only 
known to the pharmacy staff and none of the other staff, including anesthesia providers, 
surgeons, nurses, and researchers, had access to the code key unless specific safety 
breaches were declared which would have mandated aborting the investigation for the 
subject involved and supplying any necessary intervention for rescue and stabilization.  
Fortunately, no such aborting or rescue was required of any subjects involved in this 
investigation.  Randomization of the subjects was obtained by a computer generated 
randomization table, thus inhibiting any bias for drug selection by any of the staff or 
research team.  As stated above, multiple outside variables were identified and negated 
prior to the start of the study.  Each research team member was trained in data collection 
and the use of each tool.  The training, as stated in Appendix K, was carried out 
consistently for each participant and accomplished with video simulation of tool 
application as well as the use of seven case studies (Appendix L) that were unique to the 
application of each one of the three tools used in this investigation.  At the time of 
enrollment of the twentieth study subject, two team members scored the subject with all 
three tools simultaneously.  Only the designated team member’s scores were recorded, 
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but it allowed the team to validate the application of the tool in the correct manner 
through a modified inter-rater reliability exercise.  Although, at times it proved to be a 
weakness of the study, utilizing a small research team allowed there to be a greater 
amount of consistency in the application of the three tools across the spectrum of all 41 
subjects that participated in the study and from whom data was collected. 
Conclusion 
 Although Emergence Delirium is often a neglected topic in the field of anesthesia, 
the occurrence of this phenomenon can have detrimental effects for individuals 
undergoing anesthesia intervention, as well as their care givers and the families. The 
findings in this pilot study were not statistically significant, however, the data obtained 
through the implementation of this study identified areas that need to be further expanded 
upon and studied in much greater numbers.  Currently it is unknown exactly what causes 
emergence delirium.  The goal of this research investigation was aimed not only at 
examining measures to aid in the prevention of ED, but ultimately to also bring 
awareness to an often dismissed occurrence in the anesthesia community. 
 
 
 51
 
 
 
 
 
 
 
 
 
 
REFERENCES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 52
References 
 
 
American Psychiatric Association (2000).  Diagnostic and Statistical Manual of Mental 
  
Disorders (4th ed).  Text revision (DSM-IV-TR).  Washington, DC., American  
 
Psychiatric Association. 
 
Aono, J., Ueda, W., Mamiya, K., Takimoto, E., & Manabe, M. (1997). Greater 
 incidence of delirium during recovery from sevoflurane anesthesia 
 in preschool boys. Anesthesiology, 87(6), 1298-1300. 
Burns, S. (2003). Delirium during emergence from anesthesia: A case study.  
 Critical Care Nurse, 23(1), 66-69. 
Cole, J.W., Murray, D.J., McAllister, J.D., & Hirshberg, G.E. (2002). Emergence  
 behaviour in children: Defining the incidence of excitement and agitation  
 following anesthesia. Pediatric Anesthesia, 12, 442-447. 
Ebert, T., Hall, J., Barney, Jill., Urhrich, T., & Colinco, M. (2000). The effects of  
 Increasing plasma concentrations of dexmedetomidine in humans.  
Anesthesiology, 93(2), 382-394. 
Guler, G., Akin, A., Tosun, Z., Ors, S., Esmaoglu, A., & Boyaci, A., (2005). 
 Single-dose dexmedetomidine reduces agitation and provides 
 smooth extubation after pediatric adenotonsillectomy. Pediatric 
 Anesthesia, 15(9), 762-766. 
Ibacache, M.E., Munoz, H.R., Brandes, V., & Morales, A. (2004). Single-dose 
 dexmedetomidine reduces agitation after sevoflurane anesthesia in children. 
 Anesthesia Analgesia, 98, 60-63. 
 53
Kain, Z.N., Caldwell-Andrews, A.A., Maranets, I., McClain, B., Gaal, D., Mayes, L.C.,  
 Feng, R., & Zhang, H. (2004). Preoperative anxiety and emergence delirium 
 and postoperative maladaptive behaviors. Anesthesia Analgesia, 99, 1648-1654. 
Kamibayashi, T., & Maze, M. (2000). Clinical uses of alpha2-adrenergic agonist.  
 Anesthesiology, 93(5).  
Koroglu, A., Teksan, H., Sagir, O., Yucel, A., Toprak, H., I., & Ersoy, O., E. (2006).  
Anesthesia and Analgesia, 103(1), 63-69.  
Lankinen, U., Avela, R., & Tarkkila, P. (2006).  The prevention of emergence 
agitation with tropisetron or clonidine after sevoflurane anesthesia in small 
children undergoing adenoidectomy.  Anesthesia and Analgesia, 102, 1383-1386. 
Manworren, R., C., B., Paulos, C., L., & Pop, R. (2004).  Treating children for acute  
agitation in the PACU: differentiating pain and emergence delirium. Journal of 
PeriAnesthesia Nursing, 19 (3), 183-193. 
Malviya, S., Voepel-Lewis, T., Ramanurthi, R., J., Burke, C., & Tait, A., R. (2006).  
 Pediatric Anesthesia, 16, 554-559. 
Mason, K., P., Zgleszewski, S., E., Dearden, J., L., Dumont, R., S., Pirich, M., A., Stark,  
C., D., D’Angelo, P., MacPherson, S., Fontaine, P., J., Connor, L., & Zurakowski, 
D. (2006).  Anesthesia and Analgesia, 103(1), 57-62. 
Mukhtar, A., M., Obayah, E., M., & Hassona, A., M. (2006).  The use of  
dexmedetomidine in pediatric cardiac surgery.  Anesthesia and Analgesia, 103(1), 
52-56. 
O’Brien, D. (2002).  Acute postoperative delirium: Definitions, incidence, recognition,  
 and interventions.  Journal of PeriAnesthesia Nursing, 17 (6), 384-392. 
 54
Sahn, S.A., & Lakshminarayan, S. (1973).  Bedside criteria for discontinuation of  
 mechanical ventilation. Chest, 63, 1002. 
Shukry, M., Clyde, M.C., Kalarickal, P.L., & Ramadhyani, U. (2005). Does 
 dexmedetomidine prevent emergence delirium in children after 
 sevoflurane-based general anesthesia? Pediatric Anesthesia, 15(12), 1098. 
Sikich, N., & Lerman, J. (2004). Development and psychometric evaluation of the 
Pediatric Delirium Scale. Anesthesiology, 100, 1138-1145. 
Smith, H., & Elliott, J. (2001).  Alpha 2 receptors and agonist in pain management.  
 Current Opinions in Anesthesiology, 14, 513-518. 
Stoelting, R.K., & Hillier, S.C. (2006).  Handbook of Pharmacology & Physiology 
 in Anesthetic Practice, (2nd ed.), 133-142. 
Veyckemans, F. (2001).  Excitation phenomena during sevoflurane anesthesia in  
 children. Current Opinions in Anesthesiology, 14, 339-343. 
Vlessides, M. (2004). Lower incidence of post-op delirium with dexmedetomidine. 
 Anesthesiology News, February 2004, 12-13. 
Vlessides, M. (2002). Scale said to reliably evaluate delirium in pediatric patients. 
 Anesthesiology News, December 2002, 15. 
Voepel-Lewis, T., Malviya, S., & Tait, A.R. (2003). A prospective cohort study 
 of emergence agitation in the pediatric postanesthesia care unit.  
 Anesthesia Analgesia, 96, 1625-1630. 
Zub, D., Berkenbosch, J.W., & Tobias, J.D. (2005). Preliminary experience with oral  
 dexmedetomidine for procedural and anesthetic premedication. Pediatric  
 Anesthesia, 15, 932-938. 
 55
 
 
 
 
 
 
 
 
 
 
APPENDICES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 56
Appendix A 
Acceptance of Mask Tool 
1.   excellent (unafraid, cooperative, accepts mask readily) 
2.   good ( slight fear of mask, easily reassured) 
3.   fair ( moderate fear of mask, not calmed with reassurance) 
4.   poor ( terrified, crying combative) 
 
Time of Mask_____ 
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Appendix B 
ASA Physical Status Classification 
http://www.asahq.org/clinical/physicalstatus.htm
ASA Physical Status Classification  
 
PSC I  A normal healthy patient 
PSC II  A patient with mild systemic disease 
PSC III A patient with severe systemic disease 
PSC IV A patient with severe systemic disease that is a constant threat to life 
PSC V  A moribund patient who is not expected to survive without the operation 
PSC VI A declared brain-dead patient whose organs are being removed for donor 
purposes 
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Appendix C 
Parental Child Separation Tool 
1.   easy separation 
2.   whimpers but is easily reassured, but not clinging 
3.   cries and cannot be easily reassured, but not clinging to parents 
4.   crying and clinging to parents 
 
Time of Separation_____ 
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Appendix D 
Pediatric Anesthesia Emergence Delirium Scale 
1.  The child makes eye contact with the caregiver 
(4) not at all     (3) just a little     (2) quite a bit     (1) very much     (0) extremely 
2.  The child’s actions are purposeful 
(4) not at all     (3) just a little     (2)quite a bit     (1) very much      (0) extremely 
3.  The child is aware of his/her surroundings 
(4) not at all     (3) just a little     (2)quite a bit     (1) very much      (0) extremely 
4.  The child is restless 
(0) not at all     (1) just a little     (2)quite a bit     (3) very much      (4) extremely 
5.  The child is inconsolable 
(0) not at all     (1) just a little     (2)quite a bit     (3) very much      (4) extremely 
Time of ED__________  End of ED_________ 
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Appendix E 
Informational Letter 
Children’s Hospital Research Study 
 
Children’s Hospital wants to make waking up from anesthesia more comfortable for 
children. We are doing a research study on a medication, dexmedetomidine. This 
medicine is very safe because it does not slow down breathing. Dexmedetomidine 
provides pain relief and sedation, which we believe will help children wake up more 
comfortably. The information provided here will help you decide if you would like your 
child to be a part of this study. 
 
About 20% of children having surgery wake up crying, thrashing about, and are out-of-
control. This is called emergence delirium and may be harmful. It may cause them to pull 
out their IV tubing, to have more pain or to get an injury. If this happens we treat this 
condition with medicine and comfort measures like swaddling, holding gently, pacifier 
and going to parent early if able. Emergence delirium is caused from the anesthesia 
medicine used to put children to sleep, not from children being bad.  
 
The medicine we use now, midazolam, works very well to relax children before surgery 
but does not help when they are waking up. Based on studies, we believe 
dexmedetomidine will help children relax before surgery and wake up with less chance of 
emergence delirium. Once your child is admitted to the hospital floor we will ask if your 
child can be in this study.  If you agree, your child will either receive midazolam or 
dexmedetomidine to drink before surgery. The research nurse will follow your child to 
surgery and to the recovery room.   
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The research nurse will record how your child is when: 
• leaving you. 
• breathing the gas in the operating room. 
• waking up. 
 
Your child will be watched at all times to be sure he or she is safe. 
 
Dexmedetomidine has been used safely in children when given in the vein. But it has not 
been studied when given by mouth. This is why Children’s Hospital is doing research 
about it. 
 
 
MOST COMMON SIDE EFFECTS 
 
Dexmedetomidine (study medicine)  Midazolam (medicine we use now) 
         
Blood Pressure Changes Headache 
Nausea & Vomiting Drowsiness 
Fever Blood Pressure Changes 
Heart rate Changes Nausea &Vomiting 
 Confusion 
 Not Remembering 
 Coughing 
  
 
Thank you for thinking about helping out with this research. Your child will not be 
included unless you sign the research consent form before surgery. No personal 
information will be published with this research. If you have questions after you read the 
consent, please ask the research nurse or the anesthesiologist (doctor who puts people to 
sleep for surgery). 
 
Linda Smithson  (phone-541-8510) 
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Appendix F 
Informed Consent 
STUDY NUMBER_________    
 GROUP__________ 
 
East Tennessee Children’s Hospital 
University of Tennessee College of Nursing 
Parental Permission for My Child to Act as a Subject in an Experimental Study 
 
THE EFFICACY OF ORAL DEXMEDETOMIDINE AS AN ANESTHETIC PRE-
OPERATIVE MEDICATION AND AS A DETERRENT TO EMERGENCE 
DELIRIUM 
 
I. Purpose of the Study: 
Your child is being asked to participate in a clinical research study being conducted by 
Children’s Hospital and The University of Tennessee College of Nursing. The purpose of 
the study is to determine if giving dexmedetomidine orally reduces the rate and severity 
of emergence delirium (ED). Emergence delirium causes children to wake up from 
anesthesia crying, screaming and uncontrollable. It can cause harm to the children, like 
causing them to pull out their IV tubing, causing more pain, or causing an injury. This 
condition happens in about 20% of young children having anesthesia and is treated with 
medicine in the recovery room. Even if it does reduce the rate of ED, oral 
dexmedetomidine would not be beneficial if it is not a good pre-operative medicine like 
the one we use now, which is midazolam. Therefore the study will also measure if 
dexmedetomidine works as well as midazolam to relax your child before surgery. 
Anxiety will be measured by how your child separates from you at the operating room 
door and how your child accepts the anesthesia mask. 
 
Procedures to be Followed: 
Study subjects will be randomly assigned to receive either dexmedetomidine or 
midazolam in outpatient surgery for their pre-operative medicine before going to surgery. 
This will be done using a computer chart of numbers. A research nurse (RN) will follow 
your child to the operating room and recovery room. 
The research nurse will record how your child is when: 
leaving you. 
breathing the gas in the operating room. 
waking up. 
 
Your child will be watched at all times to be sure he or she is safe. 
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 A limited amount of general information that is important to the study, like age, previous 
surgery, medications etc. will be recorded. The dental surgeons are only indirectly 
involved in the study by allowing their patients to participate. 
 
The information gathered will be assigned a study number. The key that identifies the 
subjects name will be locked in the anesthesia office. The data will be kept in the 
research files and not your child’s medical chart. Upon publication there will be no 
patient identifiers used. 
 
Potential Risks of Participation in the Study: 
The most common side effects of dexmedetomidine are nausea and vomiting, blood 
pressure changes, heart rate changes, and fever. The most common side effects of 
midazolam are not remembering, headache, drowsiness, confusion, coughing, blood 
pressure changes, nausea and vomiting. Midazolam is used on most patients now and 
provides good relaxation. The study will determine if dexmedetomidine provides as much 
relaxation. A risk may be that the patients getting dexmedetomidine will not be as relaxed 
before surgery. The approximate cost of one dose of midazolam is 1/3 the approximate 
cost of the dexmedetomidine. This increased cost billed to the patient may be offset 
because less pain medicine may be needed after the subject receives dexmedetomidine. 
 
Potential Benefits: 
Your child may have less risk for emergence delirium if he/she receives 
dexmedetomidine. If your child experiences emergence delirium, it may be less severe 
after getting dexmedetomidine. The information obtained from this study will be used to 
benefit future patients. No financial reward will accompany acceptance to participate. 
 
Alternative Therapy: 
If for any reason you decide not to have your child participate in this research study, your 
child will receive the same care that other children having dental surgery with general 
anesthesia receive.  Participation is voluntary. This study does not affect any other health 
care your child is receiving, and there are no penalties to you or your child if you decline 
to participate.  
 
Confidentiality of Study: 
The information obtained by this study will be held strictly confidential and disclosure to 
third parties other than those noted below is prohibited. Under federal privacy 
regulations, you have the right to determine who has access to your child’s personal 
health information (called “protected health information” or PHI).  PHI collected in this 
study may include your child’s medical history, the results of physical exams, lab tests, x-
ray exams, and other diagnostic and treatment procedures, as well as basic demographic 
information.  By signing this permission form, you are authorizing the researchers at East 
Tennessee Children's Hospital and the University of Tennessee to have access to your 
child’s PHI collected in this study and to receive your child’s PHI from facilities where 
your child has received health care.  In addition, your child’s PHI may be shared with 
other persons involved in the conduct or oversight of this research, including the 
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Department of Health and Human Services (DHHS). The Institutional Review Board 
(IRB) at East Tennessee Children's Hospital and the University of Tennessee may review 
your child’s PHI as part of its responsibility to protect the rights and welfare of research 
subjects.  Your child’s PHI will not be used or disclosed to any other person or entity, 
except as required by law, or for authorized oversight of this research study by other 
regulatory agencies, or for other research for which the use and disclosure of your PHI 
has been approved by the IRB.  Your child’s PHI will be used only for the research 
purposes described previously in this form.  Your child’s PHI will be used until the study 
is completed. 
 You may cancel this authorization in writing at any time by contacting the 
principal investigator listed in this form.  If you cancel the authorization, continued use of 
your child’s PHI is permitted if it was obtained before the cancellation and its use is 
necessary in completing the research.  However, PHI collected after your cancellation 
may not be used in the study.  If you refuse to provide this authorization, your child will 
not be able to participate in the research study.  If you cancel the authorization, then your 
child will be withdrawn from the study.  Finally, the federal regulations allow you to 
obtain access to your child’s PHI collected or used in this study. However, in order to 
complete the research, your access to this PHI may be temporarily suspended while the 
research is in progress.  When the study is completed, your right of access to this 
information will be reinstated. 
 
Liability: 
There will be no payment to you or your child for their participation in this study, and no 
payment for treatments or injury resulting from participation in this study. 
 
Research Related Inquiries: 
You may contact Mark Cramolini, MD at 865-541-8485 or Linda Smithson, MSN, RN at 
865-541-8510 with any questions related to this research study. 
   
Patient Rights Information: 
General questions concerning your child’s rights as a participant in research protocols or 
questions about research related issues may be addressed to the Institutional Review 
Board Chairman, East Tennessee Children’s Hospital through his secretary at (865) 541-
8477 or through the University of Tennessee Office of Research at (865) 974-3466. 
 
Voluntary Participation Statement: 
Participation in this study is voluntary.  There will be no penalty or loss of benefits for 
declining to participate, and you may withdraw from the study at any time without 
penalty or loss of benefits to which you are otherwise entitled. 
 
 
Parental Permission: 
I have received a copy of this permission form.  I certify that I have read the above 
permission form and that I have received satisfactory explanations of the potential risks 
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and benefits.  I willingly volunteer and give my permission to allow my child to 
participate in this study. 
 
 
 
 
______________________________________________    
Patient Name     
   
______________________________________________ _______________ 
Signature of Parent      Date 
 
______________________________________________ _______________ 
Signature of Parent      Date 
 
______________________________________________ _______________ 
Signature of Person Obtaining Consent    Date 
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Appendix G 
Demographic Information Form 
Oral Dexmedetomidine Pre-Op Study Demographic Information 
Study Number:_____ 
Name: 
E Number: 
M Number: 
Date: 
Age: 
Gender: 
Race: 
Allergies: 
Medical Problems: 
 
Previous surgery: 
 
Anesthesia Problems: 
 
Medications: 
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Appendix H 
 
Pre-operative Dosing Protocol 
Emergence Delirium with Dexmedetomidine vs. Midazolam 
Pre-operative Dosing Protocol 
 
1. Verify consent for participation in study 
2. Verify no allergies to dexmedetomidine, clonidine, midazolam, other 
benzodiazepines or red dye. 
3. Pharmacy will provide a supply of pre-operative oral medication labeled “ED 
Study Drug-A” and “ED Study Drug-B”. 
4. Check which study drug patient is to receive: Patients whose study consent has an 
“A” at the top get the study drug labeled “A” and those with a “B” on the consent 
get the study drug labeled “B” 
5. The dose of the study drug is 0.25 milliliters/kg with a maximum dose of 10 
milliliters 
6. Study patients should never receive atropine or any anti-cholinergic medication. 
7. Should any reaction occur that you suspect may be an adverse reaction to the 
study drug, notify the study personnel. If the anesthesiologist decides it is needed, 
the identity of the study drug can be revealed by the pharmacy. 
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Appendix I 
 
Anesthesia Protocol 
 
Emergence Delirium with Dexmedetomidine vs. Midazolam 
 
Anesthesia Protocol 
 
1.   Mask induction with Sevoflurane, oxygen, and nitrous oxide 
2.  Change to maintenance Isoflurane as soon as possible 
3.  Maintain spontaneous ventilation as possible 
4.  If ventilatory support is required, avoid muscle relaxant, if possible 
5.  Avoid drugs with anti-cholinergic properties: atropine, glycopyrrolate, meperidine,  
pancuronium bromide, etc. (to avoid confusion between emergence delirium and     
anticholinergic toxicity) 
6.  Maintain anesthetic with isoflurane, oxygen and nitrous oxide. 
7.  Give every patient ondansetron 0.2 mg/kg and decadron 0.25 mg/kg as soon as  
     convenient at the beginning of the case (for anti-emesis) 
8.  Use fentanyl 1-2 micrograms/kg for narcotic analgesia 
9.  Ask dentists to use local anesthetic blocks for all root canals and extractions (and as  
     usual, record that they have done so on the anesthesia record). 
10.  Finally (and obviously), abandon any of the above guidelines/restrictions if needed  
       for safety of the patient, and let study personnel know. 
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Appendix J 
 
Extubation Criteria 
 
(Sahn, & Lakshminarayan, 1973) 
 
 
1. Resting minute ventilation of greater than ten liters 
2. The ability to voluntarily double the resting minute ventilation 
 
3. Peak negative pressure on maximal inspiration of greater than 30cm of water 
 
4. Forced vital capacity greater than ten to fifteen ml/kg 
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Appendix K 
Teaching Plan 
TEACHING PLAN 
 
 
1.  The Co-PI’s (Brian Mountain and Linda Smithson) will show the RA’s the tools and     
     explain how to use them. The symptoms of emergence delirium, anxiety on separation  
     from parents, and anxiety when receiving anesthesia from the mask will be explained. 
2.  The RA’s will practice scoring a scenario that has been video-taped for that purpose  
    and discuss it with the Co-PI. 
3.  The Co-PI’s will develop case studies to be used with video-taped scenarios. 
4.  The case studies will be videotaped. 
5.  Each member of the research team will view the videos and read the scenarios related  
     to the parent/child separation scale, mask acceptance scale and emergence delirium. 
6.  The member will then score each case study with the scale. 
 7. The Co-PI’s will grade the scores and discuss the results with the team member.  
     100% reliability is the goal. 
8.  A Co-PI and RA or two RA’s will score a subject together so that all RA’s are re- 
     graded during the study. If there is a variance the variance will be rectified in the  
     subject data and the RA will be re-trained. 
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     Appendix L 
Case Studies 
Case Study 1 
 
 As a 6-year-old child separates from his parents he starts to cry.  The mother gives 
him kiss and says she will see him soon.  The transporter tells him they are going on a 
little trip, he will need to lie on back, and will see his parents really soon.  The child stops 
crying and lies back in bed.  As they go through the doors to the surgery hallway, he 
waves to his parents. 
Case Study 2 
 As a 3-year old child is about to go into surgery, his mom is holding him at the 
surgery doors while he stands in the bed.  The mom says that she will see him really soon 
and he needed to lay down now.  The transporter says that they are going on a special trip 
and will take him on a ride.  The child starts crying and clinging onto him mom.  She 
tries to make him lie down but he starts screaming and grabbing tightly to his mom. 
Case Study 3 
 As the CRNA applies the mask to a 6-year old oral surgery patient, he tells him it 
smells a lot like bubble gum.  He tells the child to just breathe normal.  The child lies 
there quietly and is induced without incidence. 
Case Study 4 
 In the OR, the CRNA tells a 4-year old oral surgery patient that he will smell 
bubble gum in the funny looking mask.  The child starts to cry a little and pushes the 
mask away.  The CRNA asks him if he would like to hold it.  The child gingerly takes the 
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mask and smells it.  He says it smells funny.  With minimal time passing, the child is 
induced easily. 
Case Study 5 
 In the PACU, you are watching a 2-year old child recover from oral surgery.  As 
the child first awakens, she starts crying and asking for her mommy.  She starts crying 
louder and is pulling at an IV placed in her forearm.   She is trying to sit up in bed and the 
RN tries to console her and tell her she can see her mommy really soon.  She sits the bed 
up a little and the child opens her eyes and looks at the RN.  She continues to cry.  The 
RN asks if she is hurting and she says yes.  Medication is given per orders.  The child 
settles down and stops crying. 
Case Study 6 
 As a 6-year old begins to awaken from surgery in the PACU, he tries to sit up and 
slide out the side of the bed.  The RN slides him back into bed.  He immediately starts to 
cry and swing his arms.  As he does this he also wipes his arm against his surgically 
repaired nose and mouth causing bleeding.  Another RN comes over to help control the 
child and protect his safety.  The RN asks him to open his eyes, and he fails to respond.  
He continues to scream and kick in bed.  He eventually tries to stand up in bed and 
another RN and the surgeon have to come over to try to stabilize him.  The administer 
pain medicine 2 times and reach the maximum dose.  Each time he calms down for 30-45 
seconds and repeats his same actions. 
Case Study 7 
 As a 5-year old begins to awaken from surgery in the PACU, he tries to sit up and 
slide out the side of the bed.  The RN slides him back into bed.  He immediately starts to 
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cry and swing his arms.  As he does this he also wipes his arm against his surgically 
repaired nose and mouth causing bleeding.  Another RN comes over to help control the 
child and protect his safety.  The nurse administers pain medicine and he calms down and 
lies back in bed.  After approximately 5 minutes he opens his eyes and asks for his 
mommy.  The nurse assures him that he will see her really soon. 
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 Brian Wesley Mountain was born in Jacksonville, North Carolina on June 15, 
1979.  He graduated from Columbia Central High School in 1997. He attended Carson-
Newman College, located in Jefferson City, Tennessee, where he received his Bachelor 
in Science in Nursing in 2002.  Upon graduation and passing nursing boards, he worked 
in the cardiovascular intensive care unit as a registered nurse.  He was an active member 
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After working as a cardiovascular critical care nurse for four years, Brian is 
currently pursuing his Master’s in Nursing, with a concentration in Nurse Anesthesia, at 
the University of Tennessee in Knoxville, Tennessee.  While in the Nurse Anesthesia 
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for his research entitled, “The Efficacy of Oral Dexmedetomidine as an Anesthetic Pre-
operative Medication and as a Deterrent to Emergence Delirium”.   
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Phenomenon and Current Interventional Thought” at the Tennessee Association of Nurse 
Anesthetist 2006 Annual Meeting, “Hypothermic Circulatory Arrest” at the University of 
Tennessee College of Nursing, Nurse Anesthesia Concentration Basics of Anesthesia 
 75
Class, Defense of thesis for Master of Nursing entitled “The Efficacy of Oral 
Dexmedetomidine as an Anesthetic Pre-operative Medication and as a Deterrent to 
Emergence Delirium”, “The Efficacy of Oral Dexmedetomidine as an Anesthetic Pre-
operative Medication and as a Deterrent to Emergence Delirium” at the American 
Association of Nurse Anesthetist 2008  Annual Meeting.  Future plans include a job in 
Knoxville, Tennessee as a nurse anesthetist after graduation on August 18, 2008.  
 
 
